Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

TB Alliance CEO On Less Toxic Treatment Regimens, Pretomanid Plans

Jul 23 2021

• By Anju Ghangurde

Efforts To Make TB Treatment Less Toxic • Source: Alamy

Related Content

'Covidization' Of Resources Brings Huge Disruption For TB Patients, Researchers

Sep 21 2020

Six Questions For TB Alliance CEO On Pretomanid And Pricing Issues

Nov 12 2019

Hope For Price Flexibility After India Pretomanid Go-Ahead

Aug 07 2020

Related Companies

Johnson & Johnson

Pfizer Inc.

Mylan Pharmaceuticals Inc.

Viatris Inc.

Additional Topics

India Asia Pacific Research & Development Clinical Trials Infectious Diseases BioPharmaceutical

More from R&D

More from Scrip

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.